Brentuximab vedotin for relapse or progression therapy after allogeneic hematopoietic stem cell transplantation in relapsed / refractory classic Hodgkin lymphoma

被引：0
|
作者：
Mikhailova, N. [1 ]
Popova, M. [1 ]
Kondakova, E. [1 ]
Ivanova, M. [1 ]
Borzenkova, E. [1 ]
Alaynskiy, A. [1 ]
Bondarenko, S. [1 ]
Afanasyev, B. [1 ]
Babenko, E. [1 ]
机构：
[1] First St Petersburg Pavlov State Med Univ, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P728
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [31] Case of successful treatment of Hodgkin lymphoma progression after allogeneic haploidentical stem cell transplantation with combination of brentuximab vedotin therapy and donor lymphocyte infusions
    Motorin, Dmitry
    Zammoeva, Darina
    Badaev, Renat
    Babenetskaya, Diana
    Ilyina, Natalia
    Alexeeva, Yulia
    Zaritskey, Andrey
    BONE MARROW TRANSPLANTATION, 2018, 53 : 603 - 604
  • [32] Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients
    Flerlage, Jamie E.
    von Buttlar, Xinyu
    Krasin, Matthew
    Triplett, Brandon
    Kaste, Sue C.
    Metzger, Monika L.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (12)
  • [33] Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
    Salihoglu, A.
    Elverdi, T.
    Karadogan, I.
    Paydas, S.
    Ozdemir, E.
    Erdem, G.
    Karadurmus, N.
    Akyol, G.
    Kaynar, L.
    Yegin, Z. A.
    Sucak, G.
    Ozkocaman, V.
    Topcuoglu, P.
    Ozcan, M.
    Birtas, E.
    Goker, H.
    Baslar, Z.
    Ferhanoglu, B.
    ANNALS OF HEMATOLOGY, 2015, 94 (03) : 415 - 420
  • [34] Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
    Siddiqi, Tanya
    Thomas, Sandra H.
    Chen, Robert
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 79 - 85
  • [35] Brentuximab vedotin treatment in patients with relapsed or refractory Hodgkin lymphoma
    Zsuzsa, Molnar
    Imre, Pinczes Laszlo
    Klara, Piukovics
    Ildiko, Istenes
    Krisztina, Wolf
    Zoltan, Csukly
    Arpad, Szomor
    Arpad, Illes
    Zsofia, Miltenyi
    ORVOSI HETILAP, 2017, 158 (41) : 1630 - 1634
  • [36] A CASE OF REFRACTORY HODGKIN LYMPHOMA TREATED WITH BRENTUXIMAB VEDOTIN MAINTENANCE THERAPY AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
    Kondo, Hiroaki
    Osone, Shinya
    Aoi, Teruki
    Nishimoto, Sota
    Yoshida, Hideki
    Imamura, Toshihiko
    Iehara, Tomoko
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [37] Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
    Carella, Angelo Michele
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2012, 4 (01):
  • [38] The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma
    Collins, Joel
    Morris, Kirk
    Yue, Mimi
    Mcnamara, Caroline
    Weber, Nicholas
    Curley, Cameron
    Kennedy, Glen
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (08) : E145 - E145
  • [39] The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma
    Kako, Shinichi
    Izutsu, Koji
    Kato, Koji
    Kim, Sung-Won
    Mori, Takehiko
    Fukuda, Takahiro
    Kobayashi, Naoki
    Taji, Hirofumi
    Hashimoto, Hisako
    Kondo, Tadakazu
    Sakamaki, Hisashi
    Morishima, Yasuo
    Kato, Koji
    Suzuki, Ritsuro
    Suzumiya, Junji
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (02) : 132 - 138
  • [40] Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
    A. Salihoglu
    T. Elverdi
    I. Karadogan
    S. Paydas
    E. Ozdemir
    G. Erdem
    N. Karadurmus
    G. Akyol
    L. Kaynar
    ZA Yegin
    G. Sucak
    V. Ozkocaman
    P. Topcuoglu
    M. Ozcan
    E. Birtas
    H. Goker
    Z. Baslar
    B. Ferhanoglu
    Annals of Hematology, 2015, 94 : 415 - 420
12345